Grade My Investments
HomeFree Stock Grades › ANGO

AngioDynamics, Inc. (ANGO) Stock Grade

ANGO · Healthcare

A-
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$453.0M
P/E Ratio
Revenue Growth (YoY)
+9.5%
Net Margin
-11.5%
Return on Equity
Dividend Yield
None

About AngioDynamics, Inc.'s fundamentals

AngioDynamics is a medical instruments and supplies company with a market capitalization of $453.0 million that has achieved 9.5% year-over-year revenue growth. The company is currently unprofitable, reporting an 11.5% negative net margin and a net loss in its latest annual statement, which limits traditional profitability metrics. However, the company maintains positive free cash flow despite its accounting losses, suggesting it is generating sufficient operational cash to support operations and investments. The company does not pay a dividend.

Track ANGO free — no credit card required. Live grade + monthly AI report →